Osaka University researchers have made significant discoveries regarding lymphangiogenesis, the process of forming and remodeling lymphatic vessels. They focused on a protein called Polydom (or SVEP1) known to be crucial for lymphatic vessel development. Through their study, published in the Journal of Cell Biology, the team found that the binding of Polydom with another protein called Tie1 plays a vital role in lymphatic cell migration during lymphangiogenesis.
Using a solid-phase binding assay, the researchers demonstrated that Tie1 directly interacts with Polydom. They then conducted experiments using lymphatic endothelial cells and found that both Tie1 and Polydom were essential for cell migration, while other similar proteins did not have the same effect. Further investigation revealed that the binding of Polydom and Tie1 influences downstream signaling pathways such as PI3K/Akt and FoxO1, which are critical for lymphatic endothelial cell migration.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
Understanding lymphangiogenesis is crucial for the development of treatments for lymphatic system disorders, including lymphedema, a condition with no curative treatment that affects both genetic and cancer patients. By gaining insights into the mechanisms underlying lymphatic vessel remodeling, researchers can explore potential therapies for lymphedema and other lymph-related diseases, ultimately improving the quality of life for affected individuals.